About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT04650009

Physical Activity in Children With Inherited Cardiac Diseases

Use lay language. Current guidelines regarding physical activity in patients with inherited arrhythmia and cardiomyopathy are mostly dedicated to adult patients, with a special focus on sports compet...

Lead sponsor: University Hospital, Montpellier•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Hospital, Montpellier

Collaborators

Paediatric Cardiology and Rehabilitation Unit, St-Pierre Institute

Age

6 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Children from 6 to 18 years old with clinical and/or genetic diagnosis of :
•Long QT syndrome
•Brugada syndrome
•Catecholaminergic polymorphic ventricular tachycardia
•Hypertrophic cardiomyopathy
•Dilated cardiomyopathy
•Arrythmogenic right ventricular cardiomyopathy

Exclusion Criteria

•Presence of extra cardiac co-morbidity with motor or psychological repercussions hingering physical activity
•Refusal from children or parent to participate in the study

Related studies

RECRUITINGPhase 1

A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

NCT07148089 · Catecholaminergic Polymorphic Ventricular Tachycardia

RECRUITINGPhase 2/3

Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2)

NCT07277582 · Long QT Syndrome (LQTS) 2

Continuous Versus Intermittent cARdiac Electrical moNitorinG

NCT04336644 · Torsades de Pointe Caused by Drug, Long QT Syndrome

RECRUITINGPhase 2

Safety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

NCT07263139 · Catecholaminergic Polymorphic Ventricular Tachycardia

Evaluation of Exercise Testing and Physical Activity in Children and Adolescents Living With Inherited Arrhythmias

NCT06661278 · Long QT Syndrome, Catecholaminergic Polymorphic Ventricular Tachycardia Type 1, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 26, 2022Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment28

Start dateMay 2020

Last updatedMay 26, 2022

Condition

Long QT Syndrome Brugada Syndrome Catecholaminergic Polymorphic Ventricular Tachycardia Hypertrophic Cardiomyopathy Dilated Cardiomyopathy

Locations shown

Uh Montpellier

Montpellier

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 26, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions